Science and Public Policy

Papers
(The H4-Index of Science and Public Policy is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Correction to: Dynamics of expectations in the bioeconomy—Hopes, disillusionments, and conflicting futures86
Overcoming vested interests against innovation through political entrepreneurship: A comparative study of Korean mobility cases48
The Post-Normal Challenges of COVID-19: Constructing Effective and Legitimate Responses43
How policies emerge and interact with each other? A bibliometric analysis of policies in China41
Policy seduction and governance resistance? Examining public funding agencies and academic institutions on decarbonisation research41
Researchers’ institutional mobility: bibliometric evidence on academic inbreeding and internationalization39
Is renewable energy more favorable to diversity than conventional energy sources on R&D performance?35
The spatial mobility network and influencing factors of the higher education population in China29
Science diplomacy in the European and Latin American and Caribbean research infrastructure collaboration29
Making responsible research and innovation meaningful in citizen science27
Does the inclusion of non-academic reviewers make any difference for grant impact panels?22
Science diplomacy from a nation-state’s perspective: a general framing and its application to Global South countries22
Are there political cycles hidden inside collaborative innovation efficiency? An empirical study based on Chinese cities21
Missions as boundary objects for transformative change: understanding coordination across policy, research, and stakeholder communities18
Walking the talk? Innovation policy approaches to unleash the transformative potentials of the Nordic bioeconomy17
Does It Pay to Do Novel Science? The Selectivity Patterns in Science Funding17
Competition, open innovation, and growth challenges in the semiconductor industry: the case of Europe’s clusters16
Coevolution between institutions and scientific organizations: The case of IMPA16
Priorities in research portfolios: exploring the need for upstream research in cardiometabolic and mental health16
0.072221040725708